Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
Top

Lupus Treatment: B Cells, Interferon & More

print
PRINT
insite
SEARCH

Monday, November 11, 08:30–10:00. Georgia World Congress Center, Atlanta, USA

Moderators: Kenneth Kalunian, USA; Saira Sheikh, USA

  1. B Cell Therapies: How the Past Informs the Future David Isenberg, UK
  2. The Interferon Story: More to Come Richard Furie, USA
  3. Looking to the Future of Lupus Therapies Daniel Wallace, USA

Back to the ACR/ARP 2019 conference hub

print
PRINT

Related content

20-06-2019 | Systemic lupus erythematosus | Highlight | Article

Systemic lupus erythematosus: Novel therapies and targeted treatments

09-04-2019 | Systemic lupus erythematosus | News

Updated EULAR guidelines for lupus management issued

07-05-2019 | Systemic lupus erythematosus | Podcast | Article

A closer look at the EULAR guidelines for managing lupus

04-09-2019 | Systemic lupus erythematosus | Highlight | News

Preliminary trial results support further investigation of low-dose IL-2 therapy for SLE